cholestyramine resin has been researched along with framycetin in 62 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (framycetin) | Trials (framycetin) | Recent Studies (post-2010) (framycetin) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 8,151 | 460 | 653 |
| Protein | Taxonomy | cholestyramine resin (IC50) | framycetin (IC50) |
|---|---|---|---|
| 30S ribosomal protein S6 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S7 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L15 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L10 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L11 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L19 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L1 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L20 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L27 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L28 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L29 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L31 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L32 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L33 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L34 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L35 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L36 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S10 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S11 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S12 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S13 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S16 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S18 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S19 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S20 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S2 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S3 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S4 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S5 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S8 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S9 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L13 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L14 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L16 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L23 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S15 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L17 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L21 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L30 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L6 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S14 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S17 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S1 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L18 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L2 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L3 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L24 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L4 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L22 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L5 | Escherichia coli K-12 | 0.032 | |
| 30S ribosomal protein S21 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L25 | Escherichia coli K-12 | 0.032 | |
| 50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.032 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (93.55) | 18.7374 |
| 1990's | 4 (6.45) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frexinos, J | 1 |
| Schentke, KU | 1 |
| Passi, RB; Redinger, RN | 1 |
| Green, PH; Tall, AR | 1 |
| Meinders, AE | 1 |
| Caspary, WF | 1 |
| Levy, RI | 1 |
| Clopath, P; Dicato, MA | 1 |
| Miettinen, TA | 4 |
| Diament, J; Forti, N; Giannini, SD | 1 |
| Augustin, J; Greten, H; Klose, G; Middelhoff, G; Mordasini, R | 1 |
| Caspary, WF; Lankisch, PG; Tönissen, J | 1 |
| Huttunen, J | 1 |
| Longstreth, GF; Newcomer, AD | 1 |
| Sirtori, C | 1 |
| Gotto, AM; Yeshurun, D | 1 |
| Hong, RW; Rodrick, ML; Rounds, JD; van Leeuwen, PA; Wilmore, D | 1 |
| Herman, RJ; Szakacs, CB; Van Pham, JD | 1 |
| Kostner, GM | 1 |
| Kane, JP; Malloy, MJ | 2 |
| Blum, CB; Levy, RI | 1 |
| Nikkilä, EA; Tikkanen, MJ | 1 |
| Havel, RJ; Kane, JP | 1 |
| Gotto, AM; Jones, PH; Scott, LW | 1 |
| Bailey, KR; Brewer, HB; Hoeg, JM; Maher, MB | 1 |
| Stuyt, PM | 1 |
| Brewer, HB; Connor, WE; Gregg, RE; Lin, DS | 1 |
| Bailey, KR; Brewer, HB; Gregg, RE; Hoeg, JM; Maher, MB; Sprecher, DL; Zech, LA | 1 |
| Parker, F | 1 |
| Boudry, JF; Iynedjian, PB; Peters, G; Roch-Ramel, F | 1 |
| Levy, RI; Morganroth, J; Rifkind, BM | 1 |
| Andre, J | 1 |
| Dietschy, JM; Wilson, FA | 1 |
| Krikler, DM | 1 |
| Eastwood, MA | 1 |
| Fumagalli, R; Paoletti, R; Sirtori, C | 1 |
| Siede, W; Wildgrube, HJ | 1 |
| Palmer, RH | 1 |
| Fumagalli, R; Paoletti, R; Sirtori, R | 1 |
| Faergeman, O | 1 |
| Briani, G; Crepaldi, G; Fellin, R | 1 |
| Connor, WE | 1 |
| Kritchevsky, D | 1 |
| Likoff, W | 1 |
| Lewis, B | 1 |
| Borgman, RF; Haselden, FH | 1 |
| Canzler, H | 1 |
| Schade, RW | 1 |
| Azarnoff, DL; Saunders, RN | 1 |
| Samuel, P | 1 |
| Boctor, MA; Chaudhary, A; Herman, RJ; Lane, R; Szakacs, CB; Woo, D | 1 |
| Chaudhary, A; Herman, RJ; Szakacs, CB | 1 |
22 review(s) available for cholestyramine resin and framycetin
| Article | Year |
|---|---|
Drugs, alcohol and malabsorption.
Topics: Alcoholism; Aluminum Hydroxide; Animals; Cholestyramine Resin; Colchicine; Dietary Fats; Drug-Related Side Effects and Adverse Reactions; Folic Acid Deficiency; Gastrointestinal Motility; Humans; Intestinal Absorption; Intestinal Mucosa; Malabsorption Syndromes; Neomycin; Protein-Energy Malnutrition | 1979 |
[Effect and side effects of drugs on digestive and resorptive function of small intestine].
Topics: Aminosalicylic Acid; Biguanides; Bile Acids and Salts; Cardiac Glycosides; Cathartics; Cholestyramine Resin; Harmaline; Humans; Intestine, Small; Malabsorption Syndromes; Neomycin; Oligomycins; Phenytoin; Phlorhizin; Prenylamine | 1977 |
The effect of hypolipidemic drugs on plasma lipoproteins.
Topics: Aminosalicylic Acid; Animals; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Dogs; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Rats; Sitosterols | 1977 |
Recent progress in atherosclerosis research; experimental and clinical aspects.
Topics: Animals; Anticoagulants; Arteriosclerosis; Blood Platelets; Cell Division; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Endothelium; Humans; Lipoproteins; Neomycin; Nicotinic Acids; Platelet Adhesiveness; Platelet Aggregation; Thrombosis | 1978 |
[Therapeutic orientation in the hyperlipidemias].
Topics: Cholestyramine Resin; Dextrothyroxine; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Sitosterols; Triglycerides | 1979 |
The affection of lipoprotein-a by lipid lowering drugs.
Topics: Arteriosclerosis; Bezafibrate; Cholestyramine Resin; Hormones; Humans; Hypolipidemic Agents; Lipoprotein(a); Lipoproteins; Neomycin; Niacin; Nicotinic Acids; Stanozolol | 1988 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides | 1988 |
Treatment of hypercholesterolemia.
Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Treatment of hyperlipidemia.
Topics: Blood Proteins; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Costs and Cost Analysis; Diet Therapy; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Neomycin; Nicotinic Acids; Phospholipids; Sitosterols; Thyroxine; Triglycerides | 1974 |
Approach to the malabsorption syndromes associated with disordered bile acid metabolism.
Topics: Bile Acids and Salts; Biliary Fistula; Biliary Tract Diseases; Cholestyramine Resin; Chylomicrons; Colloids; Colonic Diseases; Feces; Gallbladder Diseases; Gastrointestinal Diseases; Humans; Intestinal Absorption; Intestinal Fistula; Intestinal Mucosa; Lipid Metabolism; Lipids; Liver Diseases; Macromolecular Substances; Malabsorption Syndromes; Neomycin; Pancreas; Solubility; Vitamin B 12; Xylose; Zollinger-Ellison Syndrome | 1972 |
[Drug prevention of coronary disease].
Topics: Anticholesteremic Agents; Antihypertensive Agents; Cholestyramine Resin; Clofibrate; Coronary Disease; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Neomycin | 1972 |
Therapy of lipid disorders.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet Therapy; Drug Therapy, Combination; Female; Hospitals, Psychiatric; Humans; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids; Sex Factors | 1973 |
Hypolipidemic drugs.
Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Female; Gonadal Steroid Hormones; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lignin; Lipid Metabolism; Lipid Mobilization; Male; Nafenopin; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Progestins; Sitosterols; Sterols; Thyroxine; Triglycerides | 1973 |
The pathogenesis, diagnosis and treatment of maldigestion.
Topics: Bile; Binding Sites; Celiac Disease; Cholecystokinin; Cholestyramine Resin; Diarrhea; Diet Therapy; Digestion; Fatty Acids, Nonesterified; Humans; Hydrolysis; Malabsorption Syndromes; Neomycin; Phospholipids; Secretin; Triglycerides | 1974 |
Bile acids, liver injury, and liver disease.
Topics: Animals; Bile Acids and Salts; Biliary Fistula; Chickens; Cholestyramine Resin; Cricetinae; Haplorhini; Humans; In Vitro Techniques; Liver; Liver Diseases; Neomycin; Perfusion; Rabbits; Rats | 1972 |
Measures to reduce the serum lipid levels in coronary heart disease.
Topics: Adult; Anticholesteremic Agents; Butyrates; Cholesterol; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diet Therapy; Dietary Fats; Estrogens; Humans; Hypercholesterolemia; Lipids; Middle Aged; Neomycin; Nicotinic Acids; Sterols | 1968 |
The use of pharmacologic agents in atherosclerosis therapy.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Butyrates; Carbamates; Cholestanes; Cholestyramine Resin; Clinical Trials as Topic; Estrogens; Heparin; Humans; Neomycin; Nicotinic Acids; Stereoisomerism; Sterols; Thyroxine | 1968 |
Effects of hypolipidemic drugs on bile acid metabolism in man.
Topics: Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fiber; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Plants, Medicinal; Sterols; Thyroxine | 1981 |
[Hyperlipoproteinemia type II].
Topics: Adolescent; Adult; Cecum; Child; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Ileum; Lipoproteins, LDL; Neomycin; Nicotinic Acids; Plasmapheresis; Portacaval Shunt, Surgical; Xanthogranuloma, Juvenile | 1980 |
Treatment of hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine | 1982 |
Current status of drugs used to treat hyperlipoproteinemias.
Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols | 1982 |
6 trial(s) available for cholestyramine resin and framycetin
| Article | Year |
|---|---|
Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects.
Topics: Adult; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feces; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged; Neomycin; Sitosterols | 1979 |
Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Constipation; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Neomycin; Time Factors | 1985 |
Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin.
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Clofibrate; Constipation; Depression, Chemical; Diarrhea; Drug Therapy, Combination; Dyspepsia; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nausea; Neomycin | 1973 |
The use of pharmacologic agents in atherosclerosis therapy.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Butyrates; Carbamates; Cholestanes; Cholestyramine Resin; Clinical Trials as Topic; Estrogens; Heparin; Humans; Neomycin; Nicotinic Acids; Stereoisomerism; Sterols; Thyroxine | 1968 |
Current status of drugs used to treat hyperlipoproteinemias.
Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols | 1982 |
Disposition of lorazepam in Gilbert's syndrome: effects of fasting, feeding, and enterohepatic circulation.
Topics: Adolescent; Adult; Biological Availability; Cholestyramine Resin; Chromatography, High Pressure Liquid; Diet, Fat-Restricted; Drug Interactions; Enterohepatic Circulation; Fasting; Food-Drug Interactions; Gilbert Disease; Glucuronates; Humans; Infusions, Intravenous; Lorazepam; Male; Neomycin | 1994 |
36 other study(ies) available for cholestyramine resin and framycetin
| Article | Year |
|---|---|
[Responsibility of the bile salts in certain diarrheic syndrome].
Topics: Bacteria; Bile Acids and Salts; Biliary Tract Diseases; Celiac Disease; Cholelithiasis; Cholestyramine Resin; Colon; Diarrhea; Diet; Enterohepatic Circulation; Fecal Impaction; Gastrointestinal Motility; Humans; Hydrogen-Ion Concentration; Ileum; Intestinal Absorption; Intestines; Neomycin; Oxalates; Triglycerides; Water-Electrolyte Balance | 1976 |
[Steatorrhea: pathophysiological, diagnostic and therapeutic aspects with special reference to the newest findings on the metabolism of bile acids].
Topics: Abetalipoproteinemia; Adult; Bile Acids and Salts; Celiac Disease; Cholestyramine Resin; Dietary Fats; Digestion; Humans; Infant; Lipase; Lymphangiectasis, Intestinal; Malabsorption Syndromes; Male; Middle Aged; Neomycin; Pancreatic Neoplasms; Pancreatitis; Triglycerides; Whipple Disease | 1975 |
Effects of plasma cholesterol lowering agents on hepatobiliary lipid metabolism and cholesterol turnover in the rhesus monkey.
Topics: Animals; Anticholesteremic Agents; Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Female; Haplorhini; Lipid Metabolism; Liver; Macaca mulatta; Neomycin | 1979 |
[Hyperlipoproteinemia].
Topics: Adipose Tissue; Apolipoproteins; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Fatty Acids; Humans; Hyperlipidemias; Lipid Metabolism; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Neomycin; Nicotinic Acids; Phospholipids; Triglycerides | 1979 |
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
Topics: Anion Exchange Resins; Biguanides; Cholestyramine Resin; Clofibrate; Colestipol; DEAE-Dextran; Dextrothyroxine; Drug Therapy, Combination; Estrogens; Humans; Hyperlipidemias; Lipoproteins; Neomycin; Nicotinic Acids; Progestins; Sitosterols | 1978 |
'Enteral' hyperoxaluria. Effect of cholestyramine, calcium, neomycin, and bile acids on intestinal oxalate absorption in man.
Topics: Bile Acids and Salts; Calcium; Carbon Radioisotopes; Cholestyramine Resin; Humans; Intestinal Absorption; Neomycin; Oxalates; Urinary Calculi | 1977 |
[Treatment of hyperlipidemia].
Topics: Adult; Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids | 1976 |
Drug-induced malabsorption.
Topics: Alcoholism; Aminosalicylic Acids; Antacids; Biguanides; Cathartics; Cholestyramine Resin; Colchicine; Contraceptives, Oral; Dose-Response Relationship, Drug; Ethanol; Female; Humans; Intestinal Mucosa; Malabsorption Syndromes; Neomycin | 1975 |
Lipid-lowering drugs.
Topics: Cellulose; Cholestyramine Resin; Clofibrate; Drug Evaluation; Humans; Hyperlipidemias; Lipids; Myocardial Infarction; Neomycin; Nicotinic Acids | 1975 |
[Diet and drug therapy of hyperlipoproteinemia].
Topics: Butyrates; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dietary Fats; Humans; Hyperlipidemias; Hypolipidemic Agents; Neomycin; Nicotinic Acids | 1975 |
Drug treatment of hyperlipidemia.
Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Estrogens; Halofenate; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids; Progesterone; Sitosterols | 1976 |
Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin.
Topics: Ammonia; Analysis of Variance; Animals; Cefazolin; Cholestyramine Resin; Endotoxins; Gastrointestinal Contents; Glutamine; Hepatectomy; Hepatic Encephalopathy; Isotonic Solutions; Lactulose; Male; Neomycin; Random Allocation; Rats; Rats, Inbred Strains; Sodium Chloride | 1991 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol | 1991 |
Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect.
Topics: Administration, Oral; Adult; Cholestyramine Resin; Drug Interactions; Enterohepatic Circulation; Humans; Injections, Intravenous; Lorazepam; Male; Neomycin | 1989 |
Rational drug therapy of the hyperlipoproteinemias, Part II.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol | 1986 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides | 1987 |
Comparison of six pharmacologic regimens for hypercholesterolemia.
Topics: Adult; Aged; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Retrospective Studies | 1987 |
[Drugs in hyperlipidemia].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypolipidemic Agents; Neomycin; Niacin | 1987 |
Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis.
Topics: Adult; Bile Acids and Salts; Cholestyramine Resin; Chromatography, Gas; Female; Humans; Hysterectomy; Intestinal Absorption; Lipids; Lipoproteins; Neomycin; Plants; Shellfish; Sitosterols; Xanthomatosis | 1986 |
Lipid-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides | 1985 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |
[Metabolic effects of drugs].
Topics: Celiac Disease; Cholestyramine Resin; Cyclic AMP; Diuretics; Glycolysis; Humans; Malabsorption Syndromes; Metabolism; Neomycin; Pharmacology | 1970 |
[Role of bile salts in intestinal pathology].
Topics: Bile Acids and Salts; Biliary Tract Diseases; Celiac Disease; Cholestyramine Resin; Diarrhea; Humans; Intestinal Diseases; Kanamycin; Neomycin; Zollinger-Ellison Syndrome | 1974 |
Physiology of bile acids in the ileum and colon.
Topics: Bacteroides; Bile Acids and Salts; Cholestyramine Resin; Colon; Escherichia coli; Feces; Ileum; Lactobacillus; Lignin; Neomycin; Vegetables | 1973 |
[Hypolipemic agents].
Topics: Androgens; Biological Transport; Butyrates; Cholestyramine Resin; Clofibrate; Estrogens; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipid Metabolism; Lipids; Neomycin; Nicotinic Acids; Thyroid Hormones; Triglycerides | 1973 |
Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
Topics: Adolescent; Adult; Alcohol Drinking; Body Weight; Child; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Drug Therapy, Combination; Fats, Unsaturated; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Neomycin; Nicotinic Acids; Sitosterols; Thyroxine | 1973 |
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Exercise Therapy; Heparin; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Neomycin; Nicotinic Acids; Nitrates; Stress, Physiological; Thyroxine; Triglycerides | 1972 |
Lipid lowering agents.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids | 1972 |
Classification of hyperlipidaemias.
Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Metabolic Clearance Rate; Neomycin; Nicotinic Acids; Obesity; Oxymetholone; Triglycerides | 1971 |
Cholelithiasis in rabbits: effects of several treatments on formation and dissolution of gallstones.
Topics: Animals; Atropine; Bile Acids and Salts; Cholelithiasis; Cholesterol; Cholestyramine Resin; Female; Gallbladder; Intestinal Absorption; Male; Neomycin; Neostigmine; Paraffin; Pectins; Rabbits; Terpenes; Vitamin D | 1969 |
Management of excess serum lipid.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Humans; Hyperlipidemias; Ileum; Neomycin; Triglycerides | 1971 |
[Drug therapy of hypercholesterinemias (author's transl)].
Topics: Adult; Bezafibrate; Cholestyramine Resin; Clofibric Acid; Colestipol; Dextrothyroxine; Fenofibrate; Humans; Hypercholesterolemia; Neomycin; Nicotinic Acids; Sitosterols | 1980 |
Effects of neomycin alone and in combination with cholestyramine on serum methyl sterols and conversion of acetate and mevalonate to cholesterol.
Topics: Acetates; Cholesterol; Cholestyramine Resin; Feces; Humans; Hyperlipoproteinemia Type II; Mevalonic Acid; Neomycin; Steroids; Sterols | 1982 |
Lipid-lowering drugs.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Probucol | 1980 |
Drug treatment of hyperlipidemia.
Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hyperlipidemias; Middle Aged; Neomycin; Nicotinic Acids; Probucol | 1980 |
Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins.
Topics: Adolescent; Adult; Cholestyramine Resin; Diabetes Mellitus, Type 1; Humans; Insulin; Lorazepam; Male; Neomycin; Pharmacokinetics | 1995 |